<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Young AC</submitter><funding>Anna-Greta Crafoords Stiftelse för Reumatologisk Forskning</funding><funding>NHLBI NIH HHS</funding><pagination>e70127</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12606447</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(11)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To evaluate the fecal metabolome in patients with early systemic sclerosis (SSc) compared with unaffected controls and to determine if altered metabolites are associated with specific bacterial genera in patients with early SSc.&lt;h4>Methods&lt;/h4>Stool samples and clinical data were collected from 106 patients with early SSc and 79 unaffected control patients. Targeted metabolomics was performed on fecal samples using liquid chromatography mass spectrometry, and 16S ribosomal RNA gene sequencing was used to determine the microbial composition of fecal samples.&lt;h4>Results&lt;/h4>Compared with unaffected controls, patients with early SSc had higher levels of nicotinamide, 5'-methylthioadenosine, and several short-chain fatty acids (SCFAs) including valeric acid, propionic acid, a</pubmed_abstract><journal>ACR open rheumatology</journal><pubmed_title>Characterization of the Fecal Metabolome in Patients With Early Systemic Sclerosis.</pubmed_title><pmcid>PMC12606447</pmcid><funding_grant_id>K23 HL150237</funding_grant_id><funding_grant_id>20242014</funding_grant_id><pubmed_authors>Matulionis N</pubmed_authors><pubmed_authors>Andreasson K</pubmed_authors><pubmed_authors>Jacobs JP</pubmed_authors><pubmed_authors>Volkmann ER</pubmed_authors><pubmed_authors>Young AC</pubmed_authors><pubmed_authors>Labus J</pubmed_authors><pubmed_authors>Christofk H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characterization of the Fecal Metabolome in Patients With Early Systemic Sclerosis.</name><description>&lt;h4>Objective&lt;/h4>To evaluate the fecal metabolome in patients with early systemic sclerosis (SSc) compared with unaffected controls and to determine if altered metabolites are associated with specific bacterial genera in patients with early SSc.&lt;h4>Methods&lt;/h4>Stool samples and clinical data were collected from 106 patients with early SSc and 79 unaffected control patients. Targeted metabolomics was performed on fecal samples using liquid chromatography mass spectrometry, and 16S ribosomal RNA gene sequencing was used to determine the microbial composition of fecal samples.&lt;h4>Results&lt;/h4>Compared with unaffected controls, patients with early SSc had higher levels of nicotinamide, 5'-methylthioadenosine, and several short-chain fatty acids (SCFAs) including valeric acid, propionic acid, a</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-05-17T03:19:24.64Z</modification><creation>2026-05-17T03:12:21.854Z</creation></dates><accession>S-EPMC12606447</accession><cross_references><pubmed>41221989</pubmed><doi>10.1002/acr2.70127</doi></cross_references></HashMap>